Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis
Last updated on July 2021Recruitment
- Recruitment Status
- Enrolling by invitation
- Estimated Enrollment
- 5
Summary
- Conditions
- Drug Effect
- Drug Toxicity
- Mesenchymal Stromal Cells
- Psoriasis
- Type
- Interventional
- Phase
- Phase 1Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 65 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03392311
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Chuanjian Lu, PhD Guangdong Provincial Hospital of Traditional Chinese Medicine
Get Well Soon